심혈관 디지털 헬스 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 구성 요소, 최종 사용자, 지역별, 경쟁(2021-2031년)

The global market for digital health in cardiovascular care is projected to expand significantly, from USD 41.31 Billion in 2025 to USD 63.58 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 7.45%. This sector integrates various technologies, including mobile health applications, wearable sensors, and telehealth platforms, all designed to facilitate the remote diagnosis and management of heart conditions. Key growth drivers for this market stem from the urgent need for continuous patient monitoring and the push for more cost-effective healthcare solutions, crucial for addressing the increasing prevalence of heart diseases. For instance, the American Heart Association reported in 2024 that nearly half, 48.6%, of adults in the United States suffer from some form of cardiovascular disease. This considerable disease burden is a major catalyst for the adoption of remote management tools, which aim to reduce hospital readmissions and enhance clinical outcomes.

Despite this robust growth potential, the digital health for cardiovascular market encounters considerable hurdles, primarily concerning data privacy and adherence to regulatory standards. Stringent legal frameworks governing the security of patient data pose significant obstacles to device interoperability and the secure exchange of sensitive health information across diverse platforms. These intricate regulatory requirements not only prolong the time it takes for new technologies to reach commercialization but also restrict their seamless integration into established medical practices, thereby slowing innovation within the sector.

Market Driver

The escalating global prevalence of cardiovascular diseases serves as a fundamental driver for the digital health sector, demanding urgent transformations in healthcare delivery and financing models. With heart conditions becoming increasingly common, healthcare systems are compelled to adopt remote management solutions to control costs and avoid costly hospitalizations. This financial necessity is highlighted by significant projected expenditures; for example, the American Heart Association reported in June 2024 that annual healthcare costs for cardiovascular conditions in the United States are expected to nearly quadruple from $393 billion in 2020 to $1,490 billion by 2050. This drives payers and providers to actively integrate digital platforms that facilitate preventive care and alleviate the economic burden associated with acute cardiac events.

Concurrently, the integration of Artificial Intelligence (AI) and Machine Learning (ML) for predictive diagnostics is revolutionizing the market by boosting the clinical value of wearable devices. These advanced technologies enable continuous analysis of biometric data, which substantially improves the early detection of arrhythmias and other cardiac anomalies compared to conventional diagnostic approaches. A study from Duke University Medical Center in September 2024, for instance, found that long-term continuous heart monitors increased the diagnosis of atrial fibrillation by 52% compared to standard care. This enhanced diagnostic accuracy is further bolstered by an evolving regulatory landscape that is increasingly validating these sophisticated technologies for broader clinical application, with cardiology ranking second among all specialties in 2025, featuring approximately 160 FDA-cleared clinical AI algorithms according to Cardiovascular Business.

Market Challenge

The rigorous enforcement of data privacy and regulatory compliance presents a significant obstacle to the expansion of the global digital health market for cardiovascular care. Producers of mobile applications and wearable sensors are obligated to navigate intricate legal structures to ensure their products adhere to stringent patient data protection standards. This extensive regulatory load diverts substantial capital towards compliance infrastructure rather than product innovation, consequently postponing the market entry of new remote monitoring technologies. As a result, smaller companies often find it difficult to penetrate this sector, which diminishes competition and decelerates the overall rate of technological progress benefiting cardiac patients.

Furthermore, the difficulty in safeguarding interoperable devices from data breaches inhibits swift adoption by healthcare organizations. The inherent risk of compromising sensitive health information compels these institutions to establish restrictive data-sharing protocols, which in turn impede the fluid information exchange essential for effective remote management. For example, the Healthcare Information and Management Systems Society reported that in 2025, 55 percent of healthcare organizations intended to boost their cybersecurity spending to mitigate these vulnerabilities. This reallocation of financial resources towards security and compliance underscores the economic pressure that privacy concerns exert on the industry, ultimately restricting the widespread integration of digital tools into conventional cardiovascular care.

Market Trends

The evolution of cuffless blood pressure monitoring technologies is revolutionizing hypertension management by removing the physical discomfort typically linked with conventional inflatable cuffs. This emerging trend involves embedding optical sensors into user-friendly wearable devices, allowing for continuous and passive data collection to provide a comprehensive, long-term perspective on cardiovascular health. As reported by MobiHealthNews in July 2025, Aktiia achieved FDA 510(k) clearance for its G0 Blood Pressure Monitoring System, making it the first cuffless monitor approved for over-the-counter use in the United States. This significant regulatory achievement indicates a market movement towards passive monitoring solutions, which improve user adherence and facilitate the early identification of hypertensive events without interfering with daily life.

Concurrently, a notable shift towards virtual cardiac rehabilitation models is effectively overcoming traditional barriers like geographical restrictions and inflexible scheduling that have historically hindered patient participation in recovery programs. By utilizing mobile platforms, healthcare providers can now deliver supervised exercise regimens and essential educational resources directly to patients' homes, substantially increasing adherence and clinical effectiveness. For instance, a collaboration between Mass General Brigham and Recora, announced by the Benson-Henry Institute in September 2025, highlighted a study where patients participating in Recora's virtual program experienced a 38 percent reduction in hospital readmissions compared to those in traditional center-based rehabilitation. This trend emphasizes the industry's transition towards hybrid care delivery frameworks that prioritize convenience to enhance post-acute cardiovascular outcomes.

Key Market Players

• Apple Inc.
• Philips Healthcare
• Boston Scientific Corporation
• Medtronic plc
• Fitbit, Inc.
• AliveCor, Inc.
• Withings SA
• Dexcom, Inc.
• Samsung Electronics Co., Ltd.
• Huawei Technologies Co., Ltd.

Report Scope

In this report, the Global Digital Health For Cardiovascular Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Health For Cardiovascular Market, By Component

• Software
• Hardware
• Services

Digital Health For Cardiovascular Market, By End User

• Patients
• Providers
• Payers
• Others

Digital Health For Cardiovascular Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Health For Cardiovascular Market.

Available Customizations:

Global Digital Health For Cardiovascular Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Health For Cardiovascular Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Software, Hardware, Services)
  • 5.2.2. By End User (Patients, Providers, Payers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Digital Health For Cardiovascular Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital Health For Cardiovascular Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Digital Health For Cardiovascular Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Digital Health For Cardiovascular Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By End User

7. Europe Digital Health For Cardiovascular Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Digital Health For Cardiovascular Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By End User
  • 7.3.2. France Digital Health For Cardiovascular Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Digital Health For Cardiovascular Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Digital Health For Cardiovascular Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Digital Health For Cardiovascular Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By End User

8. Asia Pacific Digital Health For Cardiovascular Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Digital Health For Cardiovascular Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By End User
  • 8.3.2. India Digital Health For Cardiovascular Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Digital Health For Cardiovascular Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Digital Health For Cardiovascular Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Digital Health For Cardiovascular Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By End User

9. Middle East & Africa Digital Health For Cardiovascular Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Digital Health For Cardiovascular Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Digital Health For Cardiovascular Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Digital Health For Cardiovascular Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By End User

10. South America Digital Health For Cardiovascular Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Digital Health For Cardiovascular Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Digital Health For Cardiovascular Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Digital Health For Cardiovascular Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Digital Health For Cardiovascular Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Apple Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Philips Healthcare
• 15.3. Boston Scientific Corporation
• 15.4. Medtronic plc
• 15.5. Fitbit, Inc.
• 15.6. AliveCor, Inc.
• 15.7. Withings SA
• 15.8. Dexcom, Inc.
• 15.9. Samsung Electronics Co., Ltd.
• 15.10. Huawei Technologies Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer